The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Self-citationAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D. A., Guiard, B. P., Guilloux, J.-P., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.017 · Cited by 1,267
Self-citationMental health: a world of depression
Smith, K. (2014) · Nature · doi:10.1038/515180a · Cited by 1,148
Cryan, J. F., Valentino, R. J., & Lucki, I. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.008 · Cited by 1,119
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672
Opioid receptors: Distinct roles in mood disorders
Lutz, P.-E., & Kieffer, B. L. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.002 · Cited by 542
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jones, R. M., Portoghese, P. S., & Carlezon, W. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046433 · Cited by 485
McLaughlin, J. P., Marton-Popovici, M., & Chavkin, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05674.2003 · Cited by 430
Furey, M. L., & Drevets, W. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1121 · Cited by 417
Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies
Võikar, V., Kõks, S., Vasar, E., & Rauvala, H. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00405-4 · Cited by 416
McEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.80 · Cited by 406
Newton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10883.2002 · Cited by 313
Shirayama, Y., Ishida, H., Iwata, M., Hazama, G., Kawahara, R., & Duman, R. S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02589.x · Cited by 307
Schuller, A. G. P., King, M. A., Zhang, J., Bolan, E., Pan, Y., Morgan, D. J., Chang, A., Czick, M. E., Unterwald, E. M., Pasternak, G. W., et al. (1999) · Nature Neuroscience · doi:10.1038/5706 · Cited by 307
Self-citationNeurobiological and clinical effects of the antidepressant tianeptine
Kasper, S., & McEwen, B. S. (2008) · CNS Drugs · doi:10.2165/00023210-200822010-00002 · Cited by 302
Antidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2C Receptors
Cryan, J. F., & Lucki, I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39013-5 · Cited by 293
Svenningsson, P., Bateup, H., Qi, H., Takamiya, K., Huganir, R. L., Spedding, M., Roth, B. L., McEwen, B. S., & Greengard, P. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05952.x · Cited by 289
Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update
Brady, K. T., McCauley, J. L., & Back, S. E. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020262 · Cited by 249
Sanacora, G., Smith, M. A., Pathak, S., Su, H.-L., Boeijinga, P. H., McCarthy, D. J., & Quirk, M. C. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.130 · Cited by 236
Fava, M., Memisoglu, A., Thase, M. E., Bodkin, J. A., Trivedi, M. H., de Somer, M., Du, Y., Leigh-Pemberton, R., DiPetrillo, L., Silverman, B., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070921 · Cited by 232
Response of the μ-opioid system to social rejection and acceptance
Hsu, D. T., Sanford, B. J., Meyers, K. K., Love, T. M., Hazlett, K. E., Wang, H., Ni, L., Walker, S. J., Mickey, B. J., Korycinski, S. T., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.96 · Cited by 225
Hsu, D. T., Sanford, B. J., Meyers, K. K., Love, T. M., Hazlett, K. E., Walker, S. J., Mickey, B. J., Koeppe, R. A., Langenecker, S. A., & Zubieta, J.-K. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.185 · Cited by 205
The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
Gassaway, M. M., Rives, M.-L., Kruegel, A. C., Javitch, J. A., & Sames, D. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.30 · Cited by 195
Self-citationSaitoh, A., Kimura, Y., Suzuki, T., Kawai, K., Nagase, H., & Kamei, J. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj04014x · Cited by 180
Opioids and consummatory behavior
Levine, A. S., Morley, J. E., Gosnell, B. A., Billington, C. J., & Bartness, T. J. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90116-9 · Cited by 179
Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats
Broom, D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00413-4 · Cited by 175 · cited 1×
“…(DOR) throughout life demonstrate increased levels of anxiety and depression-related behaviors (Filliol et al, 2000), and DOR agonists have antidepressant properties in preclinical models (Broom et al, 2002; Naidu et al, 2007; Saitoh et al, 2004; Tejedor-Real et al, 1998; Torregrossa et al, 2006).”
Evaluation of Opioid Modulation in Major Depressive Disorder
Ehrich, E., Turncliff, R., Du, Y., Leigh-Pemberton, R., Fernandez, E., Jones, R., & Fava, M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.330 · Cited by 169
Kappa-opioid ligands in the study and treatment of mood disorders
Carlezon, W. A., Béguin, C., Knoll, A. T., & Cohen, B. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.008 · Cited by 160
Are μ-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch, J., & Geißlinger, G. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.006 · Cited by 146
Novelty-Suppressed Feeding in the Mouse
Samuels, B. A., & Hen, R. (2011) · Neuromethods · doi:10.1007/978-1-61779-313-4_7 · Cited by 143
Self-citationBrase, D. A., Loh, H. H., & Way, E. L. (1977) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30865-7 · Cited by 140
The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction
Chavkin, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.137 · Cited by 136
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats
Carr, G. V., Bangasser, D. A., Bethea, T. T., Young, M., Valentino, R. J., & Lucki, I. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.183 · Cited by 127
Rives, M., Rossillo, M., Liu‐Chen, L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.387332 · Cited by 111
Tejedor‐Real, P., Micó, J. A., Smadja, C., Maldonado, R. J., Roques, B. P., & Gibert‐Rahola, J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00423-3 · Cited by 99
Torregrossa, M. M., Jutkiewicz, E. M., Mosberg, H. I., Balboni, G., Watson, S. J., & Woods, J. H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.11.005 · Cited by 98
Richards, E. M., Mathews, D. C., Luckenbaugh, D. A., Ionescu, D. F., Machado-Vieira, R., Niciu, M. J., Duncan, W. C., Nolan, N. M., Franco-Chaves, J. A., Hudzik, T., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4195-4 · Cited by 76
Genetic Determinants of Morphine Activity and Thermal Responses in 15 Inbred Mouse Strains
Belknap, J. K., Riggan, J., Cross, S., Young, E. R., Gallaher, E. J., & Crabbe, J. C. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00421-8 · Cited by 73
Negri, A., Rives, M., Caspers, M. J., Prisinzano, T. E., Javitch, J. A., & Filizola, M. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400019t · Cited by 66
Self-citationCombined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice
Almatroudi, A., Husbands, S. M., Bailey, C. P., & Bailey, S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115586937 · Cited by 49
Önder, E., Tural, Ü., & Aker, T. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.03.007 · Cited by 47
Márki, Á., Monory, K., Ötvös, F., Tóth, G., Kraßnig, R., Schmidhammer, H., Traynor, J. R., Roques, B. P., Maldonado, R. J., & Borsodi, A. D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00610-x · Cited by 43
Naidu, P. S., Lichtman, A. H., Archer, C. C., May, E. L., Harris, L. S., & Aceto, M. D. G. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.031 · Cited by 41
Switching to tianeptine in patients with antidepressant‐induced sexual dysfunction
Atmaca, M., Kuloğlu, M., Tezcan, E., & Buyukbayram, A. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.479 · Cited by 40
Wenger, G. R. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90240-2 · Cited by 34
The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers.
Grislain, L., Gelé, P., Bertrand, M., Luijten, W., Bromet, N., Salvadori, C., & Kamoun, A. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08654-4 · Cited by 30
[Misuse of tianeptine: five cases of abuse].
Leterme, L., Singlan, Y.-S., Auclair, V., et al. (2003) · PubMed · Cited by 25
Woo, Y. S., Bahk, W., Jeong, J., Lee, S., Sung, H., Pae, C., Koo, B., & Kim, W. K. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12042 · Cited by 23
Coaxil (tianeptine) in the treatment of depression in Parkinson’s disease
Levin, O. S. (2007) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-007-0029-0 · Cited by 20
Bernard, K., Pénélaud, P., Mocaër, E., & Donazzolo, Y. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182217a50 · Cited by 16
Couet, W. R., Girault, J., Latrille, F., Salvadori, C., & Fourtillan, J. B. (1990) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190130 · Cited by 16
Saatçioğlu, Ö., Erim, R., & Çakmak, D. (2006) · PubMed · Cited by 13
Social feedback activates the endogenous opioid system
Hsu, D. T., Sanford, B., Meyers, K. K., Love, T., Hazlett, K. E., Wang, H., Ni, L., Walker, S. J., Mickey, B. J., Korycinski, S. T., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.139 · Cited by 9
Cited by
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519
The role of 5-HT receptors in depression
Yohn, C. N., Gergues, M. M., & Samuels, B. A. (2017) · Molecular Brain · doi:10.1186/s13041-017-0306-y · Cited by 485
Treatment resistant depression: A multi-scale, systems biology approach
Akil, H., Gordon, J., Hen, R., Javitch, J., Mayberg, H., McEwen, B., Meaney, M. J., & Nestler, E. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.019 · Cited by 442
Self-citationHu, P., Liu, J., Maita, I., Kwok, C., Gu, E., Gergues, M. M., Kelada, F., Phan, M., Zhou, J.-N., Swaab, D. F., et al. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2410-19.2020 · Cited by 71
Self-citationHu, P., Maita, I., Phan, M. L., Gu, E., Kwok, C., Dieterich, A., Gergues, M. M., Yohn, C. N., Wang, Y., Zhou, J.-N., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01070-3 · Cited by 49
Self-citation
Metadata
- Authors
- Samuels, B. A., Nautiyal, K. M., Kruegel, A. C., Levinstein, M. R., Magalong, V. M., Gassaway, M. M., Grinnell, S. G., Han, J., Ansonoff, M. A., Pintar, J. E., Javitch, J. A., Sames, D., & Hen, R.
- Venue
- Neuropsychopharmacology
- Published
- 2017-03-17
- Volume
- 42
- Issue
- 10
- Pages
- 2052-2063
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2596669968
- Cited by
- 274
- References
- 59
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.